Back to Journals » Diabetes, Metabolic Syndrome and Obesity
Diabetes, Metabolic Syndrome and Obesity
- View all (3426)
- Volume 19, 2026 (164)
- Volume 18, 2025 (389)
- Volume 17, 2024 (428)
- Volume 16, 2023 (373)
- Volume 15, 2022 (350)
- Volume 14, 2021 (449)
- Volume 13, 2020 (486)
- Volume 12, 2019 (269)
- Volume 11, 2018 (92)
- Volume 10, 2017 (52)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Journal Articles:
- Behavioral and Psychosocial Aspects in the Management and Treatment of Diabetes and Obesity (1)
- GLP-1 Agonists: The Game-Changers in Type 2 Diabetes and Obesity Care (5)
- From Type 1 to Type 2 Diabetes and Obesity: The Impact of Continuous Glucose Monitoring (CGM) and Emerging Diabetes Management Technologies on Metabolic Health (1)
- The State of Diabetes, Metabolic Syndrome and Obesity (9)
- Managing obesity with pharmacotherapy (7)
- Understanding the Impact of Gender and Sex on Diabetes Incidence, Complications, and Treatment (1)
- Emerging therapeutic targets of diabetic nephropathy (1)
Psychological Distress and Disordered Eating in Adults Attending an Obesity Outpatient Clinic
Cyranka K, Zych Z, Cyganek K, Małecki MT, Styczeń K, Pietruś M, Dudek D, Klupa T, Matejko B
Diabetes, Metabolic Syndrome and Obesity 2026, 19:594879
Published Date: 8 June 2026
Exploring the Use of GLP-1-Based Interventions for Obesity: A Qualitative Analysis of ClinicalTrials.gov Data
Alourfi NM, Alorfi NM
Diabetes, Metabolic Syndrome and Obesity 2026, 19:575375
Published Date: 14 May 2026
Identification of Continuous Glucose Monitoring Self-Management Structured Education Programs for People with Type 1 Diabetes Mellitus: A Mixed Methodology Systematic Review
Pizirtzidou E, Karagkounis C, Bellali T, Katsiki N, Kazakos K, Muzurović E, Minasidou E
Diabetes, Metabolic Syndrome and Obesity 2026, 19:598765
Published Date: 12 May 2026
Community Pharmacists’ Knowledge and Counseling Competence on GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes Care in Türkiye: A Cross-Sectional Study
Bayram-Ozgur D, Demirtürk E, Sar Y
Diabetes, Metabolic Syndrome and Obesity 2026, 19:587750
Published Date: 3 March 2026
GLP-1 Receptor Agonist Therapy in Older Adults with Diabetes: A Qualitative Analysis of Phase 4 ClinicalTrials.gov Studies
Alourfi NM, Alorfi NM
Diabetes, Metabolic Syndrome and Obesity 2026, 19:584052
Published Date: 3 February 2026
Confluence of Diabetes Risk
Keenan HA
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4659-4660
Published Date: 20 December 2025
Revolutionizing Diabetes Care: From Tech to Therapeutics
Akturk HK, Waterman LA, Cobry EC
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4675-4682
Published Date: 20 December 2025
Diabetes: A Subspecialty of Medicine and a Matter of Public Health
Conway RB
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4645-4650
Published Date: 20 December 2025
Metabolic Disorders and Complications
Sull JW, McClain DA
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4661-4663
Published Date: 20 December 2025
Subphenotyping Obesity in Pursuit of Personalized Medicine: The Devil is in the Details
McClain DA
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4671-4673
Published Date: 20 December 2025
Editorial: Lipidology at the Dawn of a New Era
Corral P
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4665-4666
Published Date: 20 December 2025
The Rise and Rise of Type 1 and Type 2 Diabetes in Youth
DeBoer MD
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4651-4654
Published Date: 20 December 2025
The Future of Obesity Management: Bridging Pharmacologic Innovation and Public Health
Qian F, Wang L
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4667-4670
Published Date: 20 December 2025
The New Era of “Diabetes Prevention, Care and Management”: Precision Tools, Predictive Models and New Technologies
Carafa A, Maddaloni E
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4655-4657
Published Date: 20 December 2025
Effects of GLP-1RA Treatment on Long-Term Post-PCI Prognosis in T2DM Patients: A Propensity Score Matching Study
Fang B, Liu F, Luo J, Song N, Liu C, Ji W, An X, Xie Q, Yang Y, Li X
Diabetes, Metabolic Syndrome and Obesity 2025, 18:3031-3040
Published Date: 25 August 2025
Comparative Safety of GLP-1/GIP Co-Agonists Versus GLP-1 Receptor Agonists for Weight Loss in Patients with Obesity or Overweight: A Systematic Review
Xie Z, Liang Z, Xie Y, Zheng G, Cao W
Diabetes, Metabolic Syndrome and Obesity 2025, 18:2837-2849
Published Date: 12 August 2025
Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli
Cheney C, Hunter K, Klein M
Diabetes, Metabolic Syndrome and Obesity 2025, 18:1411-1418
Published Date: 2 May 2025
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets
Reed J, Bain SC, Kanamarlapudi V
Diabetes, Metabolic Syndrome and Obesity 2024, 17:2419-2456
Published Date: 13 June 2024
Effect of SophorOx® on Oxidative Stress and Body Composition in Individuals with High BMI: A Randomized Controlled Trial
Roza JM, Srivastava S
Diabetes, Metabolic Syndrome and Obesity 2024, 17:2221-2234
Published Date: 5 June 2024
DR10627, a Novel Dual Glucagon‑like Peptide‑1 and Gastric Inhibitory Polypeptide Receptor Agonist for the Treatment of Obesity and Type 2 Diabetes Mellitus
Shao Y, Chen Y, Zhu M, Liu Y, Fang C, Wang M, Sun P, Fu W, Huang J, Sheng S, Huang Y
Diabetes, Metabolic Syndrome and Obesity 2024, 17:1563-1573
Published Date: 6 April 2024
Gender Differences in the Incidence of Nephropathy and Changes in Renal Function in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study
Zhang F, Han Y, Zheng G, Li W
Diabetes, Metabolic Syndrome and Obesity 2024, 17:943-957
Published Date: 26 February 2024
The Effect of Tirzepatide on Weight, Lipid Metabolism and Blood Pressure in Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Lv X, Wang H, Chen C, Zhao Y, Li K, Wang Y, Wang L, Fu S, Liu J
Diabetes, Metabolic Syndrome and Obesity 2024, 17:701-714
Published Date: 12 February 2024
The Benefit of Healthy Lifestyle in the Era of New Medications to Treat Obesity
Dalle Grave R
Diabetes, Metabolic Syndrome and Obesity 2024, 17:227-230
Published Date: 15 January 2024
Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Patients with Overweight/Obesity
She D, Xu W, Liu J, Zhang Z, Fang P, Li R, Kong D, Xuan M, Liu Q, Pan MY, Wang Y, Xue Y
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3007-3017
Published Date: 28 September 2023
The Role of PKM2 in Diabetic Microangiopathy
Tu C, Wang L, Wei L
Diabetes, Metabolic Syndrome and Obesity 2022, 15:1405-1412
Published Date: 4 May 2022